InvestorsHub Logo
Followers 72
Posts 4246
Boards Moderated 2
Alias Born 08/21/2015

Re: GRODT014 post# 2466

Monday, 01/11/2021 4:59:28 PM

Monday, January 11, 2021 4:59:28 PM

Post# of 9427
A Study to Assess 18-Methoxycoronaridine

https://www.clinicaltrials.gov/ct2/show/NCT04292197?lead=Mind+Medicine%2C+Inc.&lead_ex=Y&draw=2&rank=1

Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 77 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single/Multiple Day Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of 18- Methoxycoronaridine Administered Orally to Normal Healthy Volunteers
Actual Study Start Date : April 14, 2020
Estimated Primary Completion Date : March 30, 2021
Estimated Study Completion Date : April 30, 2021


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNMD News